Ads
related to: Gastrointestinal stromal tumor (GIST) prognosisAdvanced GIST is a highly complex disease. Learn more about a treatment option today. Find helpful resources and information about a treatment for advanced GIST.
- GIST Resistance
Learn more about the complexity of
GIST and a treatment option.
- Support & Resources
Find helpful tools & resources to
help you and your patients.
- Patient Education
A patient and care partners guide
with treatment information.
- Distribution Fact Sheet
A resource with info about
treatment distribution.
- Patient Financial Help
Resources may be available
for your patients.
- Dosing Information
Learn more about dosing
information for your patients.
- GIST Resistance
Get great tips on joining the community and finding support throughout your GIST journey. Sign up today to receive free education, support, and information about treatments.
An Option Proven to Help Improve Overall Survival in a Stomach, Bowel or Esophagus Cancer. View More Information and Speak to Your Doctor to See If This Treatment Is Right For You.
Explore An Oral Multikinase Inhibitor Option For Gastrointestinal Stromal Tumors Here. Watch The Mechanism Of Action Video Of This Treatment For Gastrointestinal Stromal Tumors.
Search results
People also ask
What is the survival rate for gastrointestinal stromal tumors?
What is the survival rate of a GIST tumor?
What is gastrointestinal stromal tumor (GIST)?
Doctors also use a cancer's stage when talking about survival statistics. The stages for gastrointestinal stromal tumors (GIST) range from I (1) through IV (4). As a rule, the lower the number, the less the cancer has spread. A higher number, such as stage IV, means cancer has spread more.
Jun 28, 2020 · For example, GIST patients with gastrointestinal bleeding or high Ki67 index may have a poor prognosis [ [15], [16], [17], [18] ]. More evidence is needed to prove whether these prognostic parameters can be added to the risk classifications as new indicators.
- Haixin Zhang, Qi Liu
- 10.1016/j.tranon.2020.100812
- 2020
- Transl Oncol. 2020 Oct; 13(10): 100812.
Nov 1, 2022 · Based on the limited information reported in the literature, the mean survival time for patients with GIST at rare metastatic sites was >61.50 months, with a mean survival time of 59.59 months for men and 63.78 months for women. Among all the reported cases, 21 (15.31%) had a disease course ending in death.
- Xinhui Yu, Xiaoxiang Liang, Kunming Wen
- Oncol Lett. 2022 Dec; 24(6): 453.
- 10.3892/ol.2022.13573
- 2022/12
- Overview
- Symptoms and Causes
- Diagnosis and Tests
- Management and Treatment
- Prevention
- Outlook / Prognosis
- Living With
Gastrointestinal stromal tumors (GISTS) happen when cells lining your digestive tract grow and divide in an uncontrolled way, creating a mass of tissue called a tumor. GISTs can be cancerous. Some people with GIST may not notice changes in their health, while others may feel unwell or have pain or bleeding.
Contents
Arrow Down
OverviewSymptoms and CausesDiagnosis and TestsManagement and TreatmentPreventionOutlook / PrognosisLiving With
Contents
Arrow Down
What causes gastrointestinal stromal tumors (GISTs)?
All of your body's cells normally grow, divide, and then die to keep your body healthy and functioning properly. Sometimes this process gets out of control. Cells keep growing and dividing even when they are supposed to die. When the cells lining your digestive tract multiply uncontrolled, GISTs may ultimately develop. Most GISTs involve changes (mutations) in the KIT oncogene. This gene tells cells to make a protein (KIT CD117), which causes them to grow faster and divide. Advertisement
Is gastrointestinal stromal tumor (GIST) hereditary?
Most GISTs are the result of spontaneous changes in your cells and are not inherited. However, certain inherited tumor disorders can increase your risk. These include familial GIST syndrome, neurofibromatosis type 1 and Carney-Stratakis syndrome. Talk to your healthcare provider if these or any similar conditions run in your family.
What are the symptoms of gastrointestinal stromal tumors (GISTs)?
Some people have no symptoms of gastrointestinal stromal tumors (GISTs). Instead, their tumors are found accidentally during testing or surgery for another reason. Other individuals may experience the following symptoms: Decreased appetite. Tiredness. Stomach pain. Weight loss. Vomiting blood. Blood on or in the stool. Bowel obstruction. Difficulty swallowing.
How are gastrointestinal stromal tumors (GISTs) diagnosed?
Your healthcare provider will first obtain a medical history, physical exam and blood work. If GIST is suspected, your provider will order imaging or endoscopy to determine if it is cancer or another condition.
What tests will be done to diagnose a gastrointestinal stromal tumor (GIST)?
There are several tests your provider can do to diagnose your gastrointestinal stromal tumor. These tests might include: Upper endoscopy: This test may be ordered to locate the tumor and/or obtain a piece of the tumor (biopsy). In endoscopy, your doctor places a tube with a camera at the end into your mouth, through your food pipe (esophagus), and into your stomach. This allows your provider to look for a tumor. Computed tomography (CT): A scan of the abdomen and pelvis may also be obtained to help your provider understand the location and size of the tumor. CT will also help your provider decide if the tumor can be removed. Positron emission tomography (PET): A scan may also be performed to ensure your tumor is truly localized (in one place) and can be removed. If your surgeon can take out the whole thing, surgery will be performed. A pathologist will study your tumor under a microscope to find out if it is a GIST. They’ll also be able to test your tumor for genetic changes. Sometimes, the tumor is large or has spread and cannot be removed successfully. When this is the case, a biopsy is performed. Biopsy: This procedure involves using a needle or surgical procedure to remove a part of the tumor. A pathologist then studies this tissue and can usually tell if it is a GIST and check for genetic changes. GIST diagnosis and treatment are best accomplished by a team of experts working together with you. Each person needs to evaluate the advantages and limitations of each type of treatment. You’ll work with your team of physicians to develop the best approach.
What are the stages of gastrointestinal stromal tumor (GIST)?
After arriving at a cancer diagnosis, healthcare providers often try to figure out if your cancer has spread. Knowing how much cancer is in your body can help to determine how to treat it. Cancer staging can be complicated. It’s a good idea to ask your provider to explain what it means for you. For adults with GIST, providers use the American Joint Committee on Cancer (AJCC) TNM system. The AJCC TNM system is based on four factors: The size of the primary tumor (T). The spread to nearby lymph nodes (N). The spread (metastasis) to other areas of the body, such as the liver, bones, lungs and the tissue that lines the abdomen (M). How fast the cancer cells grow and divide (mitotic rate).
How are gastrointestinal stromal tumors (GISTs) treated?
The type of treatment your doctor recommends will depend on the size and location of your GIST, the results of lab tests and the stage of your disease. Your doctor will usually consider your age and general health, as well as your feelings about the treatment options. Treatment for GIST may include surgery and/or targeted drug therapy. Other therapies, such as chemotherapy and radiation therapy, are used less often.
What treatments and medications are used for gastrointestinal stromal tumors (GISTs)?
Some GISTs can be cured by surgery. However, some tumors are too large or have spread to other areas where surgery alone would not be curative. In these situations, a targeted drug therapy called imatinib may be prescribed. This is a pill taken once or twice daily by mouth. It works by attaching to the KIT protein (associated with the growth of most GISTs) and blocking its ability to let cancer cells grow. This medication can shrink the tumor or keep it from growing in about 85% of patients. Sometimes, if your tumor shrinks enough, surgery may become a treatment option. Unfortunately, your tumor may become resistant to imatinib and may start to grow again. If this happens to you, other targeted drugs may work to shrink the GIST. These include sunitinib, regorafenib and ripretinib. Whether you receive surgery or medication, your doctor will likely monitor your condition with CT scans every three to six months. Sometimes, PET scans are done to check your response to treatment.
What are the side effects of treatment for gastrointestinal stromal tumors (GISTs)?
The most common side effects of targeted therapy include: Nausea. Diarrhea or constipation. Low blood counts. Muscle cramps. Feeling tired. Changes to hair or skin. Your cancer team will monitor you closely during treatment. It’s important to tell your provider if you have changes in your health during or after cancer treatment. Care at Cleveland Clinic Gastrointestinal Stromal Tumor Treatment Find a Doctor and Specialists Make an Appointment
Who is at risk for gastrointestinal stromal tumors (GISTs)?
There are few known risk factors for GIST. Some GISTs develop because of spontaneous changes in cells. Known risk factors for GISTs are being 50 years old and older, and specific tumor disorders, including: Familial GIST syndrome: Rarely, abnormal KIT genes may be passed on from parent to child. This can increase your chances of developing GISTs. If you have familial GIST syndrome, you may develop GIST at a young age. You may have more than one GIST. Neurofibromatosis type 1: This disorder is caused by abnormal increases in cell growth. This results in the formation of tumors all over the body. These tumors can grow on nerves, causing problems with the skin, bones, eyes and elsewhere. If you have neurofibromatosis type 1, you are at higher risk of cancer, including GISTs. Carney-Stratakis syndrome: People with this rare, inherited condition are at higher risk of developing GISTs. They are also at increased risk for other nerve tumors. If you have Carney-Stratakis syndrome, you may develop GIST at a young age. You may have more than one GIST.
How can I prevent gastrointestinal stromal tumors (GISTs)?
While the risk for some cancers can be lowered by healthy lifestyle changes (such as cutting back on alcohol, quitting smoking, or maintaining a healthy weight), no known lifestyle factors contribute to your risk of GIST. Talk to your healthcare provider if you have any of the known tumor disorders that can increase your risk of GISTs.
What is the survival rate if I’m diagnosed with gastrointestinal stromal tumors (GISTs)?
The National Cancer Institute reports that the five-year relative survival rate for GIST is 83%. That means 83% of people diagnosed with GIST are alive five years later. The rate is even higher when the GIST is localized and hasn’t spread to other areas of the body. Then the survival rate reaches as high as 93%. However, if the GIST has spread to distant locations in the body, the five-year survival rate is 55%. Treatments continue to improve, along with survival rates.
Can gastrointestinal stromal tumor (GIST) be cured?
The outlook for people with GIST has improved dramatically in the last 20 years. In some patients, surgery may be curable. In others, targeted drug therapy with Tyrosine kinase inhibitors (a therapy that blocks signals needed for tumors to grow) may be necessary to shrink the tumor so it can be removed in surgery, slow its growth or help prevent it from spreading.
What questions should I ask my doctor about gastrointestinal stromal tumors (GISTs)?
It’s normal to have questions about your health, especially if you have a cancer diagnosis. It can be helpful to write down your questions and take the list with you when you meet your doctor. Talk about any concerns you have about your health, cancer surgery or treatment. Common questions include: What stage is my GIST? What does that mean for me? What symptoms should I watch out for? How long will it take for me to get better and feel more like myself? What long-term health issues might I have as a result of my cancer treatment? What is the chance that my cancer will return? What records do I need to keep about my treatment? What can I do to take care of myself and stay as healthy as possible? Can you suggest a support group that might help me?
What happens after my treatment for gastrointestinal stromal tumors (GISTs) ends?
After cancer treatment ends, all cancer survivors should have follow-up care. Follow-up care for GIST means seeing a healthcare provider for regular medical checkups once you're finished with treatment. These checkups may include bloodwork and other tests and procedures that look for any changes in your health or any problems that may occur due to your cancer treatment. These visits are also a time to check for physical and emotional problems that may develop months or years after treatment ends. Your follow-up care plan, along with a summary of your cancer treatment, is part of what is called a survivorship care plan. This plan will have all the information for you and your doctor to discuss to ensure that you get regular and thorough care after your treatment ends. Please note that it’s important that you continue to receive your routine care from your primary care provider in addition to follow-up cancer care. A note from Cleveland Clinic GISTs are rare tumors that can start anywhere in the intestinal tract. Some GISTs may cause bleeding, stomach pain or bloating. Other GISTs cause no symptoms and are detected accidentally during a procedure for another condition. Some GISTs are cancerous, but with treatment, the outlook is promising. It’s important to pay close attention to your body and let your doctor know if anything unusual happens. If you are diagnosed with GIST, remember that you are not alone. You have your family and friends, and there are support groups for nearly every type of cancer. Ask your doctor for information about these groups. You can also contact your local chapter of the American Cancer Society for more information. In addition, your doctor can refer you to a social worker or a mental health professional, both of whom can help you deal with the emotional aspects of your diagnosis. The social worker can also help you with the practical and financial issues related to the disease. Medically Reviewed Last reviewed by a Cleveland Clinic medical professional on 08/23/2021. Learn more about our editorial process.
Sep 26, 2022 · The prognosis for patients with gastrointestinal stromal tumors is based on several characteristics, principally: primary tumor site, mitotic count, and tumor size. [7] [20] Other factors contributing to the prognosis of GISTs include the presence of negative margins and avoidance of tumor rupture at resection. [19]
- Jacob Burch, Iftiker Ahmad
- 2022/09/26
- 2020
Although gastrointestinal stromal tumors may be diagnosed at any age—even in children (though this is very rare)—it occurs most often among men and women ages 50 or older. Fortunately, several types of treatment are available for GISTs.
1 Summary. Gastrointestinal stromal tumors (GIST) are of mesenchymal origin and belong to the rare malignant tumors. Men and women are affected with approximately equal frequency, and the median age of onset is 65-70 years. The most common primary sites are in the stomach and small intestine. In resectable GIST, treatment is multimodal.
Ads
related to: Gastrointestinal stromal tumor (GIST) prognosisAdvanced GIST is a highly complex disease. Learn more about a treatment option today. Find helpful resources and information about a treatment for advanced GIST.
Get great tips on joining the community and finding support throughout your GIST journey. Sign up today to receive free education, support, and information about treatments.
An Option Proven to Help Improve Overall Survival in a Stomach, Bowel or Esophagus Cancer. View More Information and Speak to Your Doctor to See If This Treatment Is Right For You.
